An open-label, randomized phase II study of adecatumumab, a...

Annals of Oncology 2010 / 02 Vol. 21; Iss. 2

An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer

Schmidt, M., Scheulen, M. E., Dittrich, C., Obrist, P., Marschner, N., Dirix, L., Schmidt, M., Ruttinger, D., Schuler, M., Reinhardt, C., Awada, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdp314
Date:
February, 2010
File:
PDF, 156 KB
english, 2010
Conversion to is in progress
Conversion to is failed